AC Immune SA
ACIU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651625
No open-market purchases or sales by AC Immune SA insiders were filed in the last 90 days; 43 institutions reported holding it in 13F filings for Q2 2026, worth $58.2M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding AC Immune SA changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 35 | 34 | −1 |
| Shares | 13.8M | 14.0M | +217.4K (+1.6%) |
| Value | $49.8M | $44.3M | −$5.52M (−11.1%) |
New holders (4)
Institutions that held AC Immune SA at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Avidity Partners Management LP | 274,876 | $869.0K | 0.02% |
| Balyasny Asset Management LLC | 25,841 | $82.0K | 0.00% |
| Mariner, LLC | 19,987 | $63.0K | 0.00% |
| China Universal Asset Management Co., Ltd. | 783 | $2.00K | 0.00% |
Sold out (5)
Institutions that held AC Immune SA at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Assenagon Asset Management S.A. | 147,435 | $532.0K |
| Susquehanna International Group, LLP | 16,546 | $60.0K |
| Dimensional Fund Advisors LP | 12,707 | $45.0K |
| Venture Visionary Partners LLC | 410 | $1.48K |
| FMR LLC | 42 | $0 |